Your browser doesn't support javascript.
loading
Pre-treatment fertility preservation and post-treatment reproduction in long-term survivors of adolescent and young adult (AYA) cancer.
Lehmann, Vicky; Vlooswijk, Carla; van der Graaf, Winette T A; Bijlsma, Rhodé; Kaal, Suzanne E J; Kerst, Jan Martijn; Tromp, Jacqueline M; Bos, Monique E M M; van der Hulle, Tom; Lalisang, Roy I; Nuver, Janine; Kouwenhoven, Mathilde C M; Lok, Christianne A R; Beerendonk, Catharina C M; Dinkelman-Smit, Marij; Husson, Olga.
Afiliación
  • Lehmann V; Department of Medical Psychology, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. v.lehmann@amsterdamumc.nl.
  • Vlooswijk C; Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands. v.lehmann@amsterdamumc.nl.
  • van der Graaf WTA; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
  • Bijlsma R; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Kaal SEJ; Department of Medical Oncology, ErasmusMC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Kerst JM; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht, The Netherlands.
  • Tromp JM; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Bos MEMM; Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
  • van der Hulle T; Department of Medical Oncology, Amsterdam University Medical Center/University of Amsterdam, Amsterdam, The Netherlands.
  • Lalisang RI; Department of Medical Oncology, ErasmusMC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Nuver J; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Kouwenhoven MCM; Department of Internal Medicine, GROW-School of Oncology and Reproduction, Maastricht UMC, Maastricht, The Netherlands.
  • Lok CAR; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • Beerendonk CCM; Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands.
  • Dinkelman-Smit M; Department of Neurology, Amsterdam University Medical Centers/University of Amsterdam, Amsterdam, The Netherlands.
  • Husson O; Department of Gynecologic Oncology, Center Gynaecologic Oncology Amsterdam, Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
J Cancer Surviv ; 2024 Feb 06.
Article en En | MEDLINE | ID: mdl-38316726
ABSTRACT

PURPOSE:

To describe recall of fertility-related consultations and cryopreservation and to examine reproductive goals and reproduction post-treatment in long-term survivors of adolescent and young adult (AYA) (age, 18-39 years) cancer.

METHODS:

This study included n = 1457 male and n = 2112 female long-term survivors (Mage = 43-45 years; 5-22 years from diagnosis) who provided self-report. Clinical data were supplied by the Netherlands Cancer Registry.

RESULTS:

Most male survivors (72.7%) recalled fertility-related consultations and 22.6% completed sperm cryopreservation. Younger age (OR = 2.8; 95%CI [2.2-3.6]), not having children (OR = 5.0; 95%CI [3.2-7.7]), testicular cancer or lymphoma/leukemia (OR = 2.8/2.5 relative to "others"), and more intense treatments (OR = 1.5; 95%CI [1.1-2.0]) were associated with higher cryopreservation rates. Time since diagnosis had no effect. Of men who cryopreserved, 12.1% utilized assisted reproductive technologies (ART). Most men (88.5%) felt their diagnosis did not affect their reproductive goals, but 7.6% wanted no (additional) children due to cancer. Half of female survivors (55.4%; n = 1171) recalled fertility-related consultations. Rates of cryopreservation were very low (3.6%), but increased after 2013 when oocyte cryopreservation became non-experimental. Of women who cryopreserved, 13.2% successfully utilized ART. Most women (74.8%) experienced no effects of cancer on reproductive goals, but 17.8% wanted no (additional) children due to cancer.

CONCLUSIONS:

Cryopreservation in men varied by patient/clinical factors and was very low in women, but data of more recently treated females are needed. Utilizing cryopreserved material through ART was rare, which questions its cost-effectiveness, but it may enhance survivors' well-being. IMPLICATIONS FOR CANCER SURVIVORS The extent to which cryopreservation positively affects survivors' well-being remains to be tested. Moreover, effects of cancer on reproductive goals require further attention, especially in women who refrain from having children due to cancer.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: J Cancer Surviv Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: J Cancer Surviv Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos